RespireRx Pharmaceuticals Inc
RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. It has two drug platforms comprising ResolutionRx, a pharmaceutical cannabinoids platform, which includes dronabinol that acts upon the CB1 and CB2 endocannabinoid receptors for use in chemotherapy-induced nausea and vomiting, … Read more
RespireRx Pharmaceuticals Inc (RSPI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.008x
Based on the latest financial reports, RespireRx Pharmaceuticals Inc (RSPI) has a cash flow conversion efficiency ratio of 0.008x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-100.96K) by net assets ($-12.30 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
RespireRx Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (1988–2022)
This chart illustrates how RespireRx Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
RespireRx Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RespireRx Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ATOSS SOFTWARE - Dusseldorf Stock Exchang
DU:AOF
|
N/A |
|
Identillect Technologies Corp
V:ID
|
0.006x |
|
E2Gold Inc
OTCQB:ETUGF
|
0.066x |
|
MASI AGRICOLA S.P.A.
F:0CY
|
N/A |
|
Osmosun SA
PA:ALWTR
|
138.991x |
|
TTM TECHNOLOGIES - Dusseldorf Stock Exchang
DU:TT1
|
0.042x |
|
Digitalist Group Oyj
HE:DIGIGR
|
0.017x |
|
CORP. FIN. ALBA
MU:CSV
|
0.004x |
Annual Cash Flow Conversion Efficiency for RespireRx Pharmaceuticals Inc (1988–2022)
The table below shows the annual cash flow conversion efficiency of RespireRx Pharmaceuticals Inc from 1988 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $-11.88 Million | $-143.91K | 0.012x | -87.32% |
| 2021-12-31 | $-10.01 Million | $-956.17K | 0.096x | +50.17% |
| 2020-12-31 | $-8.06 Million | $-513.00K | 0.064x | -2.89% |
| 2019-12-31 | $-7.44 Million | $-487.75K | 0.066x | -12.11% |
| 2018-12-31 | $-5.73 Million | $-427.37K | 0.075x | -53.42% |
| 2017-12-31 | $-4.36 Million | $-697.01K | 0.160x | -33.83% |
| 2016-12-31 | $-5.49 Million | $-1.33 Million | 0.242x | -46.59% |
| 2015-12-31 | $-2.86 Million | $-1.30 Million | 0.453x | +12.48% |
| 2014-12-31 | $-2.20 Million | $-885.87K | 0.403x | +824.20% |
| 2013-12-31 | $-4.19 Million | $-182.44K | 0.044x | +101.52% |
| 2011-12-31 | $675.91K | $-1.94 Million | -2.864x | -614.15% |
| 2010-12-31 | $2.40 Million | $1.34 Million | 0.557x | -87.75% |
| 2009-12-31 | $-1.53 Million | $-6.94 Million | 4.545x | +218.35% |
| 2008-12-31 | $3.40 Million | $-13.05 Million | -3.841x | -496.26% |
| 2007-12-31 | $16.68 Million | $-10.74 Million | -0.644x | +60.95% |
| 2006-12-31 | $8.32 Million | $-13.72 Million | -1.649x | -139.19% |
| 2005-12-31 | $15.13 Million | $-10.43 Million | -0.690x | -707.22% |
| 2004-12-31 | $23.65 Million | $-2.02 Million | -0.085x | -114.28% |
| 2003-12-31 | $-1.42 Million | $-849.89K | 0.598x | -86.84% |
| 2002-12-31 | $-591.59K | $-2.69 Million | 4.548x | -73.82% |
| 2001-12-31 | $120.28K | $2.09 Million | 17.370x | 0.00% |
| 2000-12-31 | $120.28K | $2.09 Million | 17.370x | +21139.75% |
| 1999-12-31 | $2.35 Million | $192.46K | 0.082x | -98.83% |
| 1998-12-31 | $-163.33K | $-1.14 Million | 6.986x | +42.19% |
| 1997-12-31 | $-1.03 Million | $-5.07 Million | 4.913x | +842.58% |
| 1996-12-31 | $6.61 Million | $-4.37 Million | -0.662x | +58.81% |
| 1995-12-31 | $3.30 Million | $-5.30 Million | -1.606x | 0.00% |
| 1994-12-31 | $3.30 Million | $-5.30 Million | -1.606x | -279.97% |
| 1993-12-31 | $9.70 Million | $-4.10 Million | -0.423x | -434.27% |
| 1992-12-31 | $12.64 Million | $-1.00 Million | -0.079x | +90.69% |
| 1991-12-31 | $2.00 Million | $-1.70 Million | -0.850x | +44.60% |
| 1990-12-31 | $1.46 Million | $-2.24 Million | -1.534x | -44.26% |
| 1989-12-31 | $2.52 Million | $-2.68 Million | -1.063x | -596.87% |
| 1988-12-31 | $4.98 Million | $-760.00K | -0.153x | -- |